Aso, Aurelia S.

HRN: 28-60-31  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/19/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
02/19/2026
02/26/2026
IV
300mg
Q6
Nonhealing Wound Right Foot
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Bone & JointSkin & Soft Tissue    Compliance to guidelines: